That is the title of the podcast episode I was on for AJMC’s Managed Care Cast. We discuss my recently published paper on insurance value in Duchenne’s Muscular Dystrophy (DMD). To learn more about research in DMD, check out AJMC’s DMD compendia page. The full podcast is below.
Similar Posts
New Entity Aims to Help Payers Improve Payment Integrity – MedCity News
The issue of fraud, waste and abuse in healthcare spending is a major challenge for both…
This Simple Test Could Predict Your Brain Health As You Age
Stronger functional connections involving the caudate nucleus were consistently linked to higher grip strength, regardless of…
Chris Darland, Peerbridge Health – The Health Care Blog
Health Tech Oct 14, 2024 Chris Darland is CEO of Peerbridge Health, which is the maker…
Rapport’s Stock Market Debut Reaps $154M as Novel Epilepsy Med Heads for Mid-Stage Test – MedCity News
Rapport Therapeutics, a company whose neuroscience technology comes from Johnson & Johnson, joined the public markets…
Why 31,000 Kaiser Permanente Workers Are Striking — Again
Roughly 31,000 Kaiser Permanente nurses and other healthcare professionals are planning to launch an open-ended strike…
Ground Turkey Meatballs (Juicy & Flavorful!)
Thanks to grated cold butter (my secret!), this turkey meatball recipe yields wonderfully juicy and tender…
